Abstract
Clinical management of pelvic relapses from gynecologic malignancies remains challenging. Bulky pelvic relapses often lead to symptomatic cancer-related complications and poor clinical outcomes. Options may be limited by prior surgical, chemotherapeutic, and radiation treatment. Stereotactic body radiosurgery is a novel treatment modality which allows high radiation dose delivery in a non-coplanar fashion with sub-millimeter precision utilizing a linear accelerator mounted on a robotic arm. This study details our clinical experience with stereotactic body radiosurgery for treatment of patients with pelvic relapses of gynecologic malignancies after prior pelvic radiation.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / secondary
-
Adenocarcinoma / surgery
-
Adult
-
Aged
-
Carcinoma, Papillary / drug therapy
-
Carcinoma, Papillary / secondary
-
Carcinoma, Papillary / surgery
-
Combined Modality Therapy
-
Cystadenocarcinoma, Serous / drug therapy
-
Cystadenocarcinoma, Serous / secondary
-
Cystadenocarcinoma, Serous / surgery
-
Female
-
Humans
-
Neoplasm Recurrence, Local / drug therapy
-
Neoplasm Recurrence, Local / pathology
-
Neoplasm Recurrence, Local / surgery*
-
Ovarian Neoplasms / drug therapy
-
Ovarian Neoplasms / pathology
-
Ovarian Neoplasms / surgery*
-
Pelvic Neoplasms / drug therapy
-
Pelvic Neoplasms / secondary
-
Pelvic Neoplasms / surgery*
-
Prognosis
-
Radiosurgery*
-
Uterine Cervical Neoplasms / drug therapy
-
Uterine Cervical Neoplasms / pathology
-
Uterine Cervical Neoplasms / surgery*